Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iamgold Corporation Ordinary Shares (IAG) vs Smith & Nephew plc (SNN) Price & Performance

Iamgold Corporation Ordinary SharesTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Iamgold Corporation Ordinary Shares vs Smith & Nephew plc — how do they compare? Iamgold Corporation Ordinary Shares trades at $18.79 (market cap $10.49B), while Smith & Nephew plc trades at $27.05 (market cap $11.10B). The key difference: Iamgold Corporation Ordinary Shares and Smith & Nephew plc are close in size by market cap, and Smith & Nephew plc pays a 2.95% dividend while Iamgold Corporation Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iamgold Corporation Ordinary Shares for 0 Days and Smith & Nephew plc for 120 Days on average.

IAGSNN
Market Cap
$10.49B$11.10B
Volume
3,160,9021,051,703
Sector
Basic MaterialsHealth
52-Week High
$24.57$37.17
52-Week Low
$10.96$26.42
Typical Hold Time
0 Days120 Days
Enterprise Value
$10.53B$14.13B
Dividend Yield
—2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Iamgold Corporation Ordinary Shares

No Aura AI signal available yet.

Smith & Nephew plc

SNN trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue and net income have grown steadily, reaching $6.16B and $625M in 2025, respectively, with improving margins. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. However, cash flow volatility and mixed analyst sentiment pose challenges.

The stock presents a value opportunity with reasonable valuation ratios (P/E 18.34, P/S 1.85), but risks include competitive pressures and recent CFO departure. Analyst consensus is cautious, with 65% hold ratings. Upside depends on execution of growth initiatives amid market headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IAG
100% Buy0% Sell
Avg holding period · 0 Days
SNN

No sentiment data available yet.

About Iamgold Corporation Ordinary Shares

IAMGOLD is a gold mining company with operations in Canada. It also explores and develops gold properties.

Read more on IAG →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →